CANADA LIFE ASSURANCE Co - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 153 filers reported holding PDL BIOPHARMA INC in Q3 2018. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.

Quarter-by-quarter ownership
CANADA LIFE ASSURANCE Co ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q3 2020$27,000
+8.0%
8,5780.0%0.00%
Q2 2020$25,000
+4.2%
8,5780.0%0.00%
Q1 2020$24,000
-14.3%
8,5780.0%0.00%
Q4 2019$28,000
-44.0%
8,578
-46.9%
0.00%
Q2 2019$50,000
-16.7%
16,1670.0%0.00%
Q1 2019$60,000
+33.3%
16,1670.0%0.00%
Q4 2018$45,000
+4.7%
16,1670.0%0.00%
Q3 2018$43,000
+13.2%
16,1670.0%0.00%
Q2 2018$38,000
-20.8%
16,1670.0%0.00%
Q1 2018$48,000
+9.1%
16,1670.0%0.00%
Q4 2017$44,000
-20.0%
16,1670.0%0.00%
Q3 2017$55,000
+37.5%
16,1670.0%0.00%
Q2 2017$40,000
+11.1%
16,1670.0%0.00%
Q1 2017$36,000
+5.9%
16,1670.0%0.00%
Q4 2016$34,000
-68.5%
16,167
-50.0%
0.00%
Q3 2016$108,000
+111.8%
32,334
+100.0%
0.00%
Q2 2016$51,000
-5.6%
16,1670.0%0.00%
Q1 2016$54,000
-5.3%
16,1670.0%0.00%
Q4 2015$57,000
-29.6%
16,1670.0%0.00%
Q3 2015$81,000
-22.1%
16,1670.0%0.00%
Q2 2015$104,000
-8.0%
16,1670.0%0.00%
Q1 2015$113,000
-8.9%
16,1670.0%0.00%
Q4 2014$124,000
+2.5%
16,1670.0%0.00%
Q3 2014$121,000
+105.1%
16,167
+165.7%
0.00%
Q2 2014$59,000
+20.4%
6,084
+1.3%
0.00%
Q1 2014$49,000
-3.9%
6,0060.0%0.00%
Q4 2013$51,0006,0060.00%
Other shareholders
PDL BIOPHARMA INC shareholders Q3 2018
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 2,632,000$8,817,0002.83%
AMERICAFIRST CAPITAL MANAGEMENT, LLC 551,804$1,848,543,0001.54%
Nine Chapters Capital Management LLC 24,300$81,0000.57%
GREAT POINT PARTNERS LLC 645,000$2,161,0000.55%
Virtus ETF Advisers LLC 198,901$666,0000.32%
GSA CAPITAL PARTNERS LLP 1,521,224$5,096,0000.27%
Amici Capital, LLC 200,000$670,0000.18%
Acrospire Investment Management LLC 70,622$237,0000.16%
RBF Capital, LLC 273,976$918,0000.16%
SECOR Capital Advisors, LP 383,971$1,286,0000.14%
View complete list of PDL BIOPHARMA INC shareholders